Stories about Receptor (biochemistry)
- more
European Medicines Agency Validates Application for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations
moreMerck Announces Out-Licensing Agreement for Investigational Atacicept with Vera Therapeutics
moreSemaglutide 2.4 mg injection demonstrated significant weight loss versus placebo when added to intensive behavioural therapy
moreTechnische Universität München
Immune response: memory T cells are formed earlier than previously thought
moreTechnische Universität München
Coronavirus: door opener facilates cell entry
moreMerck Advances Oncology Portfolio and Pipeline with New and Long-term Data in Multiple Cancers at ESMO 2020
moreFinal Phase II Results for UCB's Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) Published in Blood Advances
moreTechnische Universität München
Finding cortisone alternatives with fewer side effects
moreDEBIOPHARM'S NEW GENERATION RADIONUCLIDE THERAPY ADVANCES INTO CLINICAL RESEARCH IN THE FIGHT AGAINST LUNG CANCER
moreGrünenthal and Averitas Pharma Announce U.S. FDA Approval of QUTENZA® for the Treatment of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy of the Feet
moreDr. Rath Education Services BV
Micronutrient Combination Suppresses Cell 'Entry Door' For Coronavirus
moreSwitching to Ozempic® from another GLP-1 RA significantly reduced blood sugar and weight in people with type 2 diabetes in routine clinical practice
moreJennewein publishes new results on the norovirus-inhibiting effect of complex oligosaccharides
moreBreakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020
moreNEOVII Partners with Tel Aviv University to Develop Novel COVID-19 Vaccine
moreNEOVII to Develop a Novel Vaccine for COVID-19 in an Exclusive Partnership With Tel Aviv University
moreData From Merck at ASCO 2020 to Showcase Significant Clinical Advances in Cancer Care
moreDebiopharm expands its radiopharmaceutical footprint with an exclusive in-licensing agreement of 3B Pharmaceutical's targeted CAIX radiotherapy
moreERBITUX® Approved for First-line Use in China in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)
moreTechnische Universität München
Self-assembled complex porous, chiral nano-patterns arise from a simple linear building block
moreKyowa Kirin Announces Marketing Authorisation Application for Istradefylline Validated by European Medicines Agency
moreUCB Presents Final Results from Phase II Study of Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) at 2019 ASH Annual Meeting
moreMerck Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations
moreEuropean Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcinoma
moreTechnische Universität München
How roots grow hair: "Smoke detectors" in plants also control the growth of root hair
moreAbstracts highlight data on BAVENCIO as a monotherapy and in combination in multiple advanced cancers
moreNew Data at ESMO 2019 for Merck Highlight Focused Clinical Development and Commitment to Patient Care
moreCHMP Adopts Positive Opinion for BAVENCIO® (avelumab) Plus Axitinib for First-Line Treatment of Patients with Advanced Renal Cell Carcinoma
moreOzempic® Offers Superior Reductions in HbA1c and Body Weight Compared to Both Victoza® and Canagliflozin in People With Type 2 Diabetes
more
123Next